MindImmune Therapeutics, Inc.

CIK 1792522 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for MindImmune Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 5, 2026D/A0001792522-26-000001
Dec 5, 2025D0001792522-25-000002
Feb 4, 2022D0000908662-22-000006
Nov 1, 2019D0000908662-19-000238